LZAGF:OTCMKTS
Lonza Group AG
$ 695.95
arrow_upward
+0.93%(+6.44) 1D
10-р сарын 13, 13:14:39 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LZAGF...
Open
$ 664.90
High
$ 708.10
Low
$ 663.55
Mkt. cap
39.78 тэрбум
Avg. vol.
236.00
Volume
53.00
52-wk high
$ 755.96
52-wk low
$ 565.14
Beta
1.00
Shares outstanding
70.23 сая
No. of employees
20 мян
Open
$ 664.90
High
$ 708.10
Low
$ 663.55
Mkt. cap
39.78 тэрбум
Avg. vol.
236.00
Volume
53.00
52-wk high
$ 755.96
52-wk low
$ 565.14
Beta
1.00
Shares outstanding
70.23 сая
No. of employees
20 мян
News stories
From web sources and news partners
ad-hoc-news.de
·
7 цагийн өмнө
Goldman Sachs keeps Buy rating for Lonza Group stock at CHF 680.00
BigGo Finance
·
10 цагийн өмнө
Qurient, Lonza Partner on Dual-Payload ADC Business..."Expect Multiple Tech Transfers Next Year"
ad-hoc-news.de
·
11 цагийн өмнө
Lonza expands ADC platform and Lonza Group stock costs EUR 615.60
TipRanks
·
1 өдрийн өмнө
Lonza Secures Exclusive CDK7 Inhibitor Rights to Boost Dual-Payload ADC Platform
Profile
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
About Lonza Group AG
CEOWolfgang Wienand
Employees20.1 мян
Founded1897
HeadquartersБазель хот, Basel City, Швейцари
SectorHealth care
Websitelonza.com